[
  {
    "ts": "2025-12-11T07:47:40+00:00",
    "headline": "HSBC Upgrades AbbVie (ABBV) to Buy, Raises Price Target to $265",
    "summary": "AbbVie Inc. (NYSE:ABBV) is included among the 15 Best Stocks to Buy for the Long Term. On December 10, HSBC increased its price target on AbbVie Inc. (NYSE:ABBV) from $225 to $265 and also upgraded the stock to Buy. Previously, on November 5, Piper Sandler reiterated a Buy rating on ABBV with a $289 price […]",
    "url": "https://finance.yahoo.com/news/hsbc-upgrades-abbvie-abbv-buy-074740751.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "4ce36956-04de-3918-9061-2fbc320571ba",
      "content": {
        "id": "4ce36956-04de-3918-9061-2fbc320571ba",
        "contentType": "STORY",
        "title": "HSBC Upgrades AbbVie (ABBV) to Buy, Raises Price Target to $265",
        "description": "",
        "summary": "AbbVie Inc. (NYSE:ABBV) is included among the 15 Best Stocks to Buy for the Long Term. On December 10, HSBC increased its price target on AbbVie Inc. (NYSE:ABBV) from $225 to $265 and also upgraded the stock to Buy. Previously, on November 5, Piper Sandler reiterated a Buy rating on ABBV with a $289 price […]",
        "pubDate": "2025-12-11T07:47:40Z",
        "displayTime": "2025-12-11T07:47:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/84249ecfff511e6ecaf4c7c7fa22aca0",
          "originalWidth": 1920,
          "originalHeight": 1281,
          "caption": "HSBC Upgrades AbbVie (ABBV) to Buy, Raises Price Target to $265",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g_A4z51GYFMmOnX5InXPOw--~B/aD0xMjgxO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/84249ecfff511e6ecaf4c7c7fa22aca0.cf.webp",
              "width": 1920,
              "height": 1281,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JO7PTUY1uqs5Y0LWdipnYg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/84249ecfff511e6ecaf4c7c7fa22aca0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hsbc-upgrades-abbvie-abbv-buy-074740751.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hsbc-upgrades-abbvie-abbv-buy-074740751.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-11T07:30:00+00:00",
    "headline": "10 High-Yielding Dividend Stocks to Buy for 2026",
    "summary": "A stronger economy and Fed rate cuts could provide tailwinds for dividend stocks next year. Consider buying names such as AbbVie, FedEx, and Coca-Cola.",
    "url": "https://www.barrons.com/articles/10-high-yielding-dividend-stocks-buy-2026-97670656?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "5406d42f-1239-3544-8e7a-40ec0d0bab8a",
      "content": {
        "id": "5406d42f-1239-3544-8e7a-40ec0d0bab8a",
        "contentType": "STORY",
        "title": "10 High-Yielding Dividend Stocks to Buy for 2026",
        "description": "",
        "summary": "A stronger economy and Fed rate cuts could provide tailwinds for dividend stocks next year. Consider buying names such as AbbVie, FedEx, and Coca-Cola.",
        "pubDate": "2025-12-11T07:30:00Z",
        "displayTime": "2025-12-11T07:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/5406d42f-1239-3544-8e7a-40ec0d0bab8a/10-high-yielding-dividend.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/a651fdb760c3fb55e037f1439a9f4128",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YfGuwoo_VwaFhdGNVeVnvg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/a651fdb760c3fb55e037f1439a9f4128.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0c1asqKru8.vs75RiCGcOw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/a651fdb760c3fb55e037f1439a9f4128.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/10-high-yielding-dividend-stocks-buy-2026-97670656?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "XOM"
            },
            {
              "symbol": "KO"
            },
            {
              "symbol": "FDX"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PBI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-11T12:49:00+00:00",
    "headline": "Here's How AbbVie's Oncology Drugs are Aiding Top-line Growth",
    "summary": "ABBV's expanding oncology lineup, spanning new solid tumor drugs and rising Venclexta sales, is helping drive steady top-line growth.",
    "url": "https://finance.yahoo.com/news/heres-abbvies-oncology-drugs-aiding-124900498.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "6b79aa32-9f8b-3905-9def-46d9a2e0d275",
      "content": {
        "id": "6b79aa32-9f8b-3905-9def-46d9a2e0d275",
        "contentType": "STORY",
        "title": "Here's How AbbVie's Oncology Drugs are Aiding Top-line Growth",
        "description": "",
        "summary": "ABBV's expanding oncology lineup, spanning new solid tumor drugs and rising Venclexta sales, is helping drive steady top-line growth.",
        "pubDate": "2025-12-11T12:49:00Z",
        "displayTime": "2025-12-11T12:49:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/6c915f5bdd1c7ea850acb1ca1c067326",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NXvq4ox9.Dlnga3rarSarw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6c915f5bdd1c7ea850acb1ca1c067326.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ut1qVl6so81FolVpx3AkvA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6c915f5bdd1c7ea850acb1ca1c067326.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-abbvies-oncology-drugs-aiding-124900498.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-abbvies-oncology-drugs-aiding-124900498.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]